BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Santen Incorporated

Below is an extended Santen Incorporated research listing. Click here to return to the Santen Incorporated main Biocorporate entry.

Recent Publications by Santen Incorporated:

Altered distribution of aquaporin 5 and its C-terminal binding protein in the lacrimal glands of a mouse model for Sjogren's syndrome.
PURPOSE: To investigate the distribution and expression of aquaporin 5...
13th August, 2008
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Curr Eye Res. 2008 Aug;33(8):621-9.
DOI Direct Link
Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
We studied the synthetic modification of structurally similar...
5th August, 2008
Nara Research & Development Center, Santen Pharmaceutical Co., Ltd, Bioorg Med Chem Lett. 2008 Aug 15;18(16):4529-32. Epub 2008 Jul 15.
DOI Direct Link
Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
We have constructed a new ocular pharmacokinetic pharmacodynamic (PK/PD)...
2nd August, 2008
Santen Pharmaceutical Biol Pharm Bull. 2008 Aug;31(8):1590-5.
Conformation-activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity.
We found 4-pyridylmethylthio derivative 1 to be very effective in using...
17th July, 2008
Research and Development Center, Santen Pharmaceutical Co. Ltd, 8916-16 Bioorg Med Chem Lett. 2008 May 1;18(9):2939-43. Epub 2008 Mar 29.
DOI Direct Link
Rapid selection in chickens of subpopulations within ArkDPI-derived infectious bronchitis virus vaccines.
We examined spike (S) gene sequences of the virus populations of four...
24th June, 2008
Department of Pathobiology, 264 Greene Hall, College of Veterinary Avian Pathol. 2008 Jun;37(3):293-306.
DOI Direct Link
Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
We have established an ocular pharmacokinetic/pharmacodynamic (PK/PD)...
20th June, 2008
Santen Pharmaceutical Co., Ltd., Nara Research and Development Center, Biol Pharm Bull. 2008 May;31(5):970-5.
SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo.
Tumor necrosis factor-alpha (TNF-alpha) is known to play a crucial role in...
30th May, 2008
Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Eur J Pharmacol. 2008 Jul 7;588(2-3):309-15. Epub 2008 Apr 20.
DOI Direct Link
Patients do not know the level of training of their doctors because doctors do not tell them.
SETTING: Although patients should know the level of training of the...
14th May, 2008
Department of Higher Education Leadership, Policy Organization, Vanderbilt J Gen Intern Med. 2008 May;23(5):607-10. Epub 2007 Dec 21.
DOI Direct Link
Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells.
OBJECTIVE: To determine the intrinsic cytotoxicity of five...
29th February, 2008
Santen Incorporated, Curr Med Res Opin. 2008 Feb;24(2):419-24.
DOI Direct Link
Chaperones for rectal and genital examinations in the emergency department: what do patients and physicians want?
BACKGROUND: The objective of this study was to compare patients'...
1st February, 2008
Department of Emergency Medicine, Vanderbilt School of Medicine, South Med J. 2008 Jan;101(1):24-8.
DOI Direct Link
Bucillamine mechanism inhibiting IL-1beta-induced VEGF production from fibroblast-like synoviocytes.
We investigated the bucillamine (Buc) mechanism inhibiting interleukin...
11th January, 2008
Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Int Immunopharmacol. 2007 Dec 5;7(12):1569-76. Epub 2007 Aug 16.
DOI Direct Link
Effects of the new ethacrynic acid oxime derivative SA12590 on intraocular pressure in cats and monkeys.
To evaluate the pharmacological characteristics of SA12590, a new...
22nd September, 2007
Research and Development Center, Santen Pharmaceutical Co. Ltd., 8916-16 Biol Pharm Bull. 2007 Aug;30(8):1445-9.
First death.
We investigated the bucillamine (Buc) mechanism inhibiting interleukin...
13th September, 2007
Vanderbilt University School of Medicine, Nashville, TN, USA. Acad Emerg Med. 2007 Sep;14(9):825-6.
DOI Direct Link
Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
Timolol has mainly been used topically for the treatment of glaucoma. It...
25th July, 2007
Santen Oy, Tampere, Finland. Drug Metab Dispos. 2007 Jul;35(7):1135-41. Epub 2007 Apr 12.
DOI Direct Link
Industrial perspective in ocular drug delivery.
In the development of a commercial drug product, the formulator must...
16th February, 2007
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1258-68. Epub 2006 Sep 15.
DOI Direct Link

«Santen Incorporated

This page contained an extended Santen Incorporated research listing. Click here to return to the Santen Incorporated main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.